Skip to main content
Cureus logoLink to Cureus
. 2021 May 28;13(5):e15289. doi: 10.7759/cureus.15289

Gastroesophageal Reflux Disease in the Young Population and Its Correlation With Anxiety and Depression

Pooja Bai 1, Shehar Bano 2, Sameet Kumar 3, Priyanka Sachdev 1, Ahmed Ali 4, Pariya Dembra 5, Parkash Bachani 1, Simra Shahid 5, Amna Jamil 6,, Amber Rizwan 7
Editors: Alexander Muacevic, John R Adler
PMCID: PMC8236209  PMID: 34194886

Abstract

Introduction

Stress and anxiety may disrupt normal GI function and lead to several GI disorders, including gastroesophageal reflux disease (GERD). In this study, we aimed to predict the prevalence of GERD in young patients and its association with anxiety and depression.

Material and Methods

This cross-sectional study enrolled 2,500 participants from the general public, with an age range of 18 to 40 years. Diagnosis of GERD was made via the Frequency Scale for the Symptoms of GERD (FSSG) questionnaire. The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depression.

Results

GERD was diagnosis in 401 (16.0%) participants. Anxiety was significantly more common in participants with GERD compared to participants without GERD (40.3% vs. 19.5%; p < 0.01). Similarly, participants with GERD had a higher prevalence of depression compared to participants without GERD (42.6% vs. 18.3%; p < 0.01).

Conclusion

GERD is highly prevalent among the young population. Anxiety and depression are significantly more prevalent in patients with GERD. Hence, the young population must be thoroughly screened for GERD to minimize the risk of long-term complications. Furthermore, patients diagnosed with GERD should be screened for depression and anxiety.

Keywords: anxiety, depression, gerd, association, pakistan

Introduction

Gastroesophageal reflux disease (GERD) is among the most prevalent gastrointestinal (GI) conditions globally, with approximately 10-20% of the western population suffering from it [1,2]. It is a chronic GI disease characterized by regurgitation of gastric contents and acid from the stomach into the esophagus, leading to chest discomfort, dyspepsia, bad breath, and heartburn [3]. GERD is suggested to have multifactorial pathogenesis with decreased pressure at the lower esophageal sphincter (LES), with delayed gastric emptying playing a significant role [3-5]. Other risk factors include hiatal hernia, obesity, obstructive sleep apnea, and helicobacter pylori gastritis. The majority of GERD patients get symptomatic relief with an antacid, but, in some cases, the response to antacid in addition to proton pump inhibitors is low. GERD significantly impacts the quality of life and precipitates poor mental well-being [6,7].

Psychological factors, including stress and anxiety, may contribute to GI disorders. Several studies have found a strong link between psychological disorders and GI functionality. Stress and anxiety may disrupt the normal GI function and lead to several GI disorders, including GERD. Similarly, poor GI health may trigger anxiety and depression in the patients [8,9]. Many studies have been carried out to establish the association between GERD and anxiety and depression. These studies have shown contrasting results. While some report a significant association between GERD and anxiety, others suggest no link between acid reflux and anxiety levels [10-14]. These contrasting results urge the need for further studies to achieve a clearer understanding of the association between GERD and psychological factors. Attributing to the stressful lifestyle, the prevalence of depression and anxiety remains higher in the younger population [15]. Therefore, this study aims to assess the correlation between psychological disorders and GERD in young patients. It shall guide the clinicians toward optimal management of the condition and prevent the psychological factors from worsening the disease symptomatology, treatment outcomes, and its deleterious effect on the quality of life in patients with GERD.

Materials and methods

This cross-sectional study was conducted in various cities of Pakistan. After taking informed consent, 2,500 participants from the public, in the age group 18 to 40 years, were enrolled in the study. Verbal informed consent was taken from participants. Participants' demographics were noted in a self-structured questionnaire. Diagnosis of GERD was made via the Frequency Scale for the Symptoms of GERD (FSSG) questionnaire [16]. Each response was assigned a score for the frequency of each symptom as follows: 0, never; 1, occasionally; 2, sometimes; 3, often; and 4, always. Patients with scores more than 10 were labeled as having GERD [16]. Based on the FSSG criteria, patients diagnosed with GERD were labeled as the case group, and those negative were included in the reference group. The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depression. Cut-off score was less than 8 on each subscale of anxiety and depression [14]. The interviewer filled the questionnaire after explaining each question to participants.

Statistical analysis was performed using the Statistical Package for Social Sciences® (SPSS) software version 23.0 (IBM Corp., Armonk, NY, USA). Categorical data such as gender, age distribution, anxiety, and depression were presented as frequency and percentages. The chi-square was applied to compare the prevalence of depression and anxiety in participants with and without GERD. A p-value of less than 0.05 meant that the difference between both groups is significant, and the null hypothesis will be rejected.

Results

GERD was diagnosed in 401 (16.0%) participants. It was more common in males compared to females (62.5% vs. 37.4%; p < 0.01). Smoking was significantly more common in GERD-positive participants compared to GERD-negative participants (49.8% vs. 14.9%; p < 0.01) (Table 1).

Table 1. Demographics of the participants.

BMI, body mass index, GERD, gastroesophageal reflux disease

Characteristics GERD Positive (n = 401) GERD Negative (n = 2,099) p-Value
Gender (%)
Male 251 (62.5%) 1,001 (47.6%) <0.01
Female 150 (37.4%) 1,098 (52.4%)
Age in years (%)
18-30 271 (67.5%) 974 (46.4%) <0.01
31-40 130 (32.5%) 1,125 (53.6%)
Smoking (%)
Yes 200 (49.8%) 313 (14.9%) <0.01
No 201 (50.2%) 1,786 (85.1%)
BMI more than 25 kg/m2
Yes 191 (47.6%) 541 (25.7%) <0.01
No 210 (52.4%) 1,558 (74.3%)

Anxiety was significantly more common in participants with GERD (40.3% vs. 19.5%; p < 0.01). Similarly, participants with GERD had a higher prevalence of depression compared to participants without GERD (42.6% vs. 18.3%; p < 0.01) (Table 2).

Table 2. Prevalence of anxiety and depression using the HADS score.

GERD, gastroesophageal reflux disease, HADS, Hospital Anxiety and Depression Scale

HADS Score Anxiety Depression
GERD Positive (n = 401) GERD Negative (n = 2,099) p-Value GERD Positive (n = 401) GERD Negative (n = 2,099) p-Value
Less than 8 162 (40.3%) 411 (19.5%) <0.01 171 (42.6%) 385 (18.3%) <0.01
More than 8 139 (59.7%) 1,688 (80.5%) 230 (57.4%) 1,714 (81.7%)

Discussion

Our study demonstrated that anxiety and depression were more common in GERD-positive participants in comparison to those without GERD. Moreover, our study indicated that GERD was more prevalent among smokers and male participants.

In compliance with this study, Oh et al. also found an association of depression and anxiety with GERD [14]. Similarly, Yang et al. showed the negative impact of mental disorders on people having GERD symptoms [17]. A high body mass index (BMI) was a common factor of GERD in our study. Obesity causes an elevation in the gastroesophageal pressure, leading to the development of hiatal hernia, which is associated with esophagitis [18]. Moreover, smoking plays a significant role in causing GERD by lowering LES resting pressure, as proved in our study [19]. The anti-reflux mechanism of the esophagus consists of the LES, the angle of His, and muscles of the diaphragm. GERD occurs when gastric acid enters the distal esophagus due to inappropriate relaxation of the LES, further leading to irritation due to the stimulation of chemoreceptors [20]. Some of the risk factors associated with GERD are smoking, high BMI, anxiety, and depression [21]. These patients often face social interaction problems, and consistent reflux can lead to chronic fatigue and sleeping difficulty. This further triggers anxiety and depression symptoms. Hence, identifying triggering factors can help such patients in reducing anxiety, as patients will be proactive in controlling their daily activities [22]. This study will assist people in identifying lifestyle and behavioral modifications to reduce GERD symptoms. These modifications include dietary modification, smoking cessation, and weight reduction. Moreover, it further highlights the fact that people with symptoms should be encouraged for GERD screening and to educate them regarding triggering factors.

This is the first large-scale study on GERD and its association with anxiety and depression in the local setting, targeting the young population. The sample was collected from various cities and thus was diverse. However, since it was a cross-sectional survey, the association between GERD and psychological symptoms could not be established definitely. Further large-scale prospective studies are needed to confirm the association between GERD and psychological diseases.

Conclusions

There is a positive correlation between GERD and anxiety and depression. Our study found that GERD is highly prevalent in the young population. We speculate that the rigorous lifestyle and high prevalence of depression and anxiety among the young population contribute to symptoms of GERD. Therefore, to minimize the risk of long-term complications, the young population must be screened for GERD. Furthermore, patients diagnosed with GERD should undergo screening for depression and anxiety.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. Jinnah Sindh Medical University issued approval JSMU/IRB/2020/12

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.Epidemiology and natural history of gastroesophageal reflux disease. Savarino E, Marabotto E, Bodini G, et al. Minerva Gastroenterol Dietol. 2017;63:175–183. doi: 10.23736/S1121-421X.17.02383-2. [DOI] [PubMed] [Google Scholar]
  • 2.Pharmacological management of GERD: where does it stand now? Hershcovici T, Fass R. Trends Pharmacol Sci. 2011;32:258–264. doi: 10.1016/j.tips.2011.02.007. [DOI] [PubMed] [Google Scholar]
  • 3.The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. https://pubmed.ncbi.nlm.nih.gov/16928254/ Am J Gastroenterol. 2006;101:1900–1920. doi: 10.1111/j.1572-0241.2006.00630.x. [DOI] [PubMed] [Google Scholar]
  • 4.Salivary growth factors and cytokines are not deficient in patients with gastroesophageal reflux disease or Barrett's esophagus. Kongara K, Varilek G, Soffer EE. Dig Dis Sci. 2001;46:606–609. doi: 10.1023/a:1005615703009. [DOI] [PubMed] [Google Scholar]
  • 5.Symptomatic reflux disease: the present, the past and the future. Boeckxstaens G, El-Serag HB, Smout AJ, Kahrilas PJ. Gut. 2014;63:1185–1193. doi: 10.1136/gutjnl-2013-306393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Effectiveness of proton pump inhibitors in nonerosive reflux disease. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Clin Gastroenterol Hepatol. 2004;2:656–654. doi: 10.1016/s1542-3565(04)00288-5. [DOI] [PubMed] [Google Scholar]
  • 7.Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results. Galmiche JP. Drugs. 2006;66:7–13. doi: 10.2165/00003495-200666001-00003. [DOI] [PubMed] [Google Scholar]
  • 8.Biopsychosocial aspects of functional gastrointestinal disorders [Online ahead of print] Van Oudenhove L, Crowell MD, Drossman DA, et al. Gastroenterology. 2016 doi: 10.1053/j.gastro.2016.02.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.The effect of emotional stress and depression on the prevalence of digestive diseases. Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. J Neurogastroenterol Motil. 2015;21:273–282. doi: 10.5056/jnm14116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J. Aliment Pharmacol Ther. 2007;26:683–691. doi: 10.1111/j.1365-2036.2007.03411.x. [DOI] [PubMed] [Google Scholar]
  • 11.Effects of anxiety and depression in patients with gastroesophageal reflux disease. Kessing BF, Bredenoord AJ, Saleh CM, Smout AJ. Clin Gastroenterol Hepatol. 2015;13:1089–1095. doi: 10.1016/j.cgh.2014.11.034. [DOI] [PubMed] [Google Scholar]
  • 12.Anxiety is linked to new-onset dyspepsia in the swedish population: a 10-year follow-up study. Aro P, Talley NJ, Johansson SE, Agréus L, Ronkainen J. Gastroenterology. 2015;148:928–937. doi: 10.1053/j.gastro.2015.01.039. [DOI] [PubMed] [Google Scholar]
  • 13.The association between gastroesophageal reflux disease with sleep quality, depression, and anxiety in a cohort study of Australian men. On ZX, Grant J, Shi Z, et al. J Gastroenterol Hepatol. 2017;32:1170–1177. doi: 10.1111/jgh.13650. [DOI] [PubMed] [Google Scholar]
  • 14.Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Oh JH, Kim TS, Choi MG, et al. https://pubmed.ncbi.nlm.nih.gov/20431758/ Gut Liver. 2009;3:259–265. doi: 10.5009/gnl.2009.3.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Epidemiology of anxiety disorders in the 21st century. Bandelow B, Michaelis S. Dialogues Clin Neurosci. 2015;17:327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Development and evaluation of FSSG: frequency scale for the symptoms of GERD. Kusano M, Shimoyama Y, Sugimoto S, et al. J Gastroenterol. 2004;39:888–891. doi: 10.1007/s00535-004-1417-7. [DOI] [PubMed] [Google Scholar]
  • 17.Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. Yang XJ, Jiang HM, Hou XH, Song J. World J Gastroenterol. 2015;21:4302–4309. doi: 10.3748/wjg.v21.i14.4302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Am J Gastroenterol. 2008;103:1349–1354. doi: 10.1111/j.1572-0241.2008.01909.x. [DOI] [PubMed] [Google Scholar]
  • 19.Inhibitory effect of smoking on the lower esophageal sphincter. Dennish GW, Castell DO. N Engl J Med. 1971;284:1136–1137. doi: 10.1056/NEJM197105202842007. [DOI] [PubMed] [Google Scholar]
  • 20.The esophagogastric junction. Mittal RK, Balaban DH. N Engl J Med. 1997;336:924–932. doi: 10.1056/NEJM199703273361306. [DOI] [PubMed] [Google Scholar]
  • 21.Association between anxiety and depression and gastroesophageal reflux disease: results from a large cross-sectional study. Choi JM, Yang JI, Kang SJ, et al. J Neurogastroenterol Motil. 2018;24:593–602. doi: 10.5056/jnm18069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lifestyle modifications in adults and older adults with chronic gastroesophageal reflux disease (GERD) Commisso A, Lim F. Crit Care Nurs Q. 2019;42:64–67. doi: 10.1097/CNQ.0000000000000239. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES